Unlabelled: ESSENTIALS: An IgA paraprotein with anti-thrombin activity was not associated with a severe bleeding phenotype. This observation challenges the paradigm that anticoagulant therapy necessarily increases bleeding risk. Characterization of the antibody showed that it specifically binds to thrombin exosite I. A therapeutic drug with the properties of this antibody might be an antithrombotic that doesn't cause bleeding.
Background: We report the case of a 54-year-old female who presented with a traumatic subdural hemorrhage. Coagulation tests were markedly prolonged due to the presence of an anti-thrombin IgA paraprotein at 3 g L(-1) . The patient made a complete recovery and has had no abnormal bleeding during a 7-year follow-up, despite the persistence of the paraprotein.
Objectives: To determine how the paraprotein prolonged clotting tests by defining its target and its epitope.
Methods: The paraprotein was purified and added to normal pooled plasma for in vitro clotting assays. Binding studies were conducted to determine the affinity of the IgA for thrombin. The Fab was isolated and crystallized with thrombin.
Results: The purified IgA was sufficient to confer the patient's in vitro coagulation profile in normal pooled plasma, and was found to bind specifically and with high affinity to thrombin. A crystal structure of the Fab fragment in complex with thrombin revealed an exosite I interaction involving CDRH3 of the antibody.
Conclusions: Although the patient originally presented with a subdural bleed, the hematoma resolved without intervention, and no other bleeding event occurred during the subsequent 7 years. During this period, the patient's IgA paraprotein levels have remained constant at 3 g L(-1) , suggesting that the presence of a high-affinity, exosite I-directed antibody is consistent with normal hemostasis. A therapeutic derivative of this antibody might therefore permit antithrombotic dose escalation without an associated increase in the risk of bleeding.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jth.13171 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib.
Australas J Dermatol
November 2024
Sir Peter McCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Sneddon-Wilkinson (SW) disease is rare condition which typically occurs in the context of a monoclonal immunoglobulin and treatment options have not been well studied. Here we present a case of a 65-year-old female with SW with underlying, otherwise indolent, lymphoplasmacytic lymphoma (LPL) with an IgA paraprotein, who achieved a complete skin remission with the administration of the Bruton Tyrosine Kinase inhibitor (BTKi), acalabrutinib.
View Article and Find Full Text PDFEvaluation of serum protein electrophoresis and immunofixation in dogs seropositive for various vector-borne pathogens.
Vet Clin Pathol
December 2024
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Background: Canine vector-borne diseases (VBDs) induce non-specific dysproteinemias, detectable by serum protein electrophoresis (SPE). VBDs have been reported to induce a monoclonal gammopathy pattern. Monoclonal gammopathies are commonly the result of paraprotein (M-protein) produced by an immunoglobulin-secreting neoplasm.
View Article and Find Full Text PDFIgA monoclonal gammopathies are accompanied by higher total TGF-β1 levels than IgG or IgM monoclonal gammopathies.
Scand J Immunol
December 2024
Department of Protein Engineering and Biochemistry, Institute of Virology, Vaccines and Sera, Torlak, Belgrade, Serbia.
Article Synopsis
- The study investigates the relationship between TGF-β1 levels and different types of monoclonal immunoglobulins (paraproteins) in individuals diagnosed with monoclonal gammopathy.
- It specifically compares total TGF-β1 levels in people with IgA, IgG, and IgM paraproteins, finding significantly higher levels of TGF-β1 in those with IgA, indicating its potential role in the disease progression.
- The findings suggest that higher TGF-β1 levels may be linked to the IgA isotype, which is associated with a less favorable prognosis, highlighting the importance of TGF-β1 in IgA monoclonal gammopathies.
Warning values of serum total kappa/lambda ratio for M-proteinemia.
BMC Immunol
October 2024
Department of Clinical Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China.
Background: To introduce the serum total kappa/lambda ratio (K/L) in humoral immunity testing reports to improve the detection rate of M-proteinemia.
Methods: 156 M protein-positive and 5464 M protein-negative samples confirmed by serum immunofixation electrophoresis(sIFE) were accumulated from January 2021 to December 2023 in the First Affiliated Hospital of Soochow University and the contents of immunoglobulins (IgG, IgA, IgM, kappa and lambda) were tested by Beckman IMMAGE800. All the samples were divided into two groups by time: the modeling group and the validation group.
Soluble B-cell maturation antigen (sBCMA) is overexpressed on multiple myeloma (MM) cells. We investigated whether sBCMA levels correlated with other myeloma tumor volume indicators and its utility in monitoring oligo-secretory/non-secretory (O-S/Non-S) MM. In 115 patients with newly diagnosed MM, sBCMA was compared with M-protein levels, bone marrow plasma cells (BMPCs), circulating tumor cells (CTCs), and total diffusion volume (tDV; estimated by whole-body diffusion-weighted magnetic resonance imaging) at diagnosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!